Sensitivity analysis using FAST and EFAST reduces a data-driven model of pembrolizumab therapy in de novo metastatic MSI-H/dMMR CRC to two simpler versions that reproduce original trajectories.
Pharmacodynam- ics of subcutaneous recombinant human interleukin-10 in healthy volunteers
1 Pith paper cite this work. Polarity classification is still indexing.
1
Pith paper citing it
fields
q-bio.QM 1years
2025 1verdicts
CONDITIONAL 1representative citing papers
citing papers explorer
-
Sensitivity analysis-guided model reduction of a mathematical model of pembrolizumab therapy for de novo metastatic MSI-H/dMMR colorectal cancer
Sensitivity analysis using FAST and EFAST reduces a data-driven model of pembrolizumab therapy in de novo metastatic MSI-H/dMMR CRC to two simpler versions that reproduce original trajectories.